• Labcorp agreed to acquire MLM Medical Labs, a global central and specialty laboratory provider with operations in the US, Germany, South Africa.
• Deal expands Labcorp’s central lab and biomarker capabilities for clinical trials; financial terms were not disclosed.
• Transaction adds a wholly owned lab network spanning four continents: North America, Europe, Asia, Africa.
• MLM’s Africa footprint includes the continent’s first fully CAP-accredited central laboratory, strengthening coverage in key clinical research markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC42159) on September 08, 2026, and is solely responsible for the information contained therein.